BENEFIT AND SAFETY OF INCOBOTULINUMTOXINA FOR EARLY MANAGEMENT OF POST-STROKE SPASTICITY IN A PATIENT WITH SARS-COV-2: A CASE REPORT

OBJECTIVE: To describe a case of early management of post-stroke spasticity treated with incobotulinumtoxinA (IncoA) in a patient with SARS-CoV-2 (COVID-19). Scarce information is available on this subject, as the COVID-19 pandemic has necessitated postponement of interventions in infected and clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordero-GarcÍa, Carlos, SÁEnz De Tejada SÁnchez, María del Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Foundation for Rehabilitation Information 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215229/
https://www.ncbi.nlm.nih.gov/pubmed/34276907
http://dx.doi.org/10.2340/20030711-1000065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215229/
https://www.ncbi.nlm.nih.gov/pubmed/34276907
http://dx.doi.org/10.2340/20030711-1000065

Ejemplares similares